MA SONGJIANG (President) sold 0.1% of their position (2.24K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $26.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/19/2025ACC: 0001140361-25-009424
DirectorOfficer· President
Since Oct 2023
-2.24K
Net shares
Net seller
$26.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.24K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$12.09
Trade value
$24.18K
% of position
0.1%
3/17/2025
2.83M→2.83M
Common Stock
Indirect
Shares
−242.00
Price / share
$10.24
Trade value
$2.48K
% of position
0.0%
3/18/2025
2.83M→2.83M
Total
Net shares
−2.24K
Net value
-$26.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/17/2025 | S · Sale | −2K | $12.09 | $24.18K | 0.1% | 2.83M | 2.83M |
| Common Stock Indirect | 3/18/2025 | S · Sale | −242.00 | $10.24 | $2.48K | 0.0% | 2.83M | 2.83M |
| Total | −2.24K | -$26.66K | ||||||
Derivative Transactions0
No derivative transactions reported